| Literature DB >> 32288648 |
Julia Kim1, Mary Allen Staat2.
Abstract
Over the past decade there has been a dramatic increase in international adoptions in the United States. While most adopted children will have common illnesses, others may have unique medical issues as a result of the conditions in their birth country requiring a broadened differential diagnosis. Knowledge of these issues is essential in the management of these patients. This review will predominately focus on infectious disease issues commonly seen in international adoptees but will also discuss other medical conditions and some of the psychosocial issues which may be encountered by caregivers in the emergency department.Entities:
Year: 2004 PMID: 32288648 PMCID: PMC7129062 DOI: 10.1016/j.cpem.2004.01.005
Source DB: PubMed Journal: Clin Pediatr Emerg Med ISSN: 1522-8401
Figure 1Top 10 countries of origin with percentages of international adoptees coming into the United States in 2002.1
Screening Tests for Internationally Adopted Children3, 7, 14, 15
| Infectious Disease Screening: | Other Screening Tests: |
|---|---|
| Hepatitis B virus serology | Complete blood count with red blood cell indices |
| Hepatitis B surface antigen | Hemoglobin electrophoresis |
| Hepatitis B surface antibody | Glucose-6-phosphate dehydrogenase level |
| Hepatitis B core antibody | Lead level |
| Hepatitis C virus antibody | Thyroid stimulating hormone |
| Syphilis serology | |
| Nontreponemal tests (RPR, VDRL, ART) | |
| Treponemal tests (MHA-TP, FTA-ABS) | |
| HIV 1 and 2 serology | |
| Stool for ova and parasites (3 specimens) | |
| Stool for Giardia lamblia and Cryptosporidia antigen (1 specimen) | |
| Mantoux (PPD) intradermal tuberculin skin test |
ART, Automated reagin test; FTA-ABS, fluorescent treponemal antibody absorption; MHA-TP, microhemagglutination-T pallidum; PPD, purified protein derivative; RPR, rapid plasma reagin; VDRL, Venereal Disease Research Laboratory.
Also assess 6 months after arrival.
Serologic Testing Available for Immunization Verification7, 29
| Children ≥ 5 Months of Age: | Children ≥ 12 Months of Age: |
|---|---|
| Diphtheria IgG ELISA | Diphtheria IgG ELISA |
| Tetanus IgG ELISA | Tetanus IgG ELISA |
| Polio neutralizing antibody to serotypes 1–3 | Polio neutralizing antibody to serotypes 1–3 |
| Hepatitis B surface antibody | Hepatitis B surface antibody |
| Rubeola (measles) antibody | |
| Mumps antibody | |
| Rubella antibody | |
| Varicella antibody |
ELISA, Enzyme-linked immunosorbent assay; IgG, immunoglobulin G.
Figure 2Geographic distribution of Hepatitis B prevalence.8
Pathogenic and Non-Pathogenic Intestinal Parasites
| Parasite Type | Pathogens | Non-Pathogens |
|---|---|---|
| Protozoa | ||
| Helminthes | ||
| Nematodes (roundworms) | ||
| Cestodes (tapeworms) | ||
Figure 3Malaria-endemic countries in the Americas, 2002.8
Figure 4Malaria-endemic countries in Africa, the Middle East, Asia, and the South Pacific, 2002.8